DFDA

Activity Pacing / Energy Management

Treatment for Chronic Fatigue Syndrome

Typical Dosage: Individualized, e.g., managing activity within individual energy envelope, taking regular rest breaks

Effectiveness
65%
Safety Score
95%
Clinical Trials
30
Participants
3K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
Individualized, e.g., managing activity within individual energy envelope, taking regular rest breaks
Time to Effect
1-3 months
Treatment Duration
Lifetime
Evidence Quality
MODERATE
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,000
Side Effect Mgmt:$0
Total Annual:$1,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$154
Cost per Remission
$3,333
Activity Pacing / Energy Management Outcomes

for Chronic Fatigue Syndrome

Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+65%
Remission Rate
+3%
Common Side Effects
Frustration
+5%
Social isolation
+3%

Sources:

tandfonline.com
researchgate.net
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov